Decipher Genomics Resource for Intelligent Discovery

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000,000

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2040

Conditions
Prostate CancerBladder CancerRenal Cancer
Interventions
OTHER

Decipher Cancer Classifier

The Decipher are gene expression-based tests that are used to better risk stratify or characterize tumor biology that are commercially available through Veracyte, Inc CLIA \& CAP certified laboratory in San Diego, CA

Sponsors
All Listed Sponsors
collaborator

Veracyte, Inc.

INDUSTRY

lead

GenomeDx Biosciences Corp

INDUSTRY